Novonesis (Novozymes) B (NZM2)
FSX
Real-time Data
06:00 AM
Day's Range
56.9652 wk Range
44.99Overview - NZM2 - Novonesis (Novozymes) B
Key Statistics
Valuation
Enterprise Value
29.34B
P/E (Trailing)
‪41.83‬
P/E (Forward)
‪30.75‬
PEG Ratio
‪-5.57‬
Price / Sales (TTM)
‪6.17‬
Price / Book
‪2.38‬
EV / EBITDA
‪18.23‬
Profitability
Gross Margin
‪55.69%‬
Profit Margin
‪14.69%‬
Operating Margin
‪23.43%‬
Return on Assets
‪3.78%‬
Return on Equity
‪5.76%‬
Ownership
Shares Outstanding
466.24M
Float
347.61M
Held by Insiders
‪15.80%‬
Held by Institutions
‪37.12%‬
Price stats
Beta
‪0.63‬
50-Day Avg
‪57.43‬
200-Day Avg
‪53.20‬
Dividends
Payout Ratio
‪63.98%‬
Frequency
Semi-Annual
Market Cap - NZM2 - Novonesis (Novozymes) B
Peers - NZM2 - Novonesis (Novozymes) B
Peer Comparison
Compared with companies in Specialty Chemicals listed on FSX.
Profile Summary - NZM2 - Novonesis (Novozymes) B
About
Novonesis (Novozymes) B is the Class B share of Novonesis A/S, a leading biotechnology company headquartered in Lyngby, Denmark. Formed in 2024 through the merger of Novozymes and Chr. Hansen, it holds a dominant near-50% market share in industrial enzymes and microbial solutions worldwide. The company develops and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
